87 filings
Page 3 of 5
8-K
jsrxci ih7fhx
10 Feb 23
Departure of Directors or Certain Officers
4:05pm
8-K
jsq r3i2v
9 Jan 23
Regulation FD Disclosure
4:08pm
8-K
i2g4vzchcj4de70t
15 Dec 22
Vigil Neuroscience Appoints David Gray, Ph.D., as Chief Scientific Officer and Announces Changes to Executive Team
4:15pm
8-K
qpp eff5s3wv05
14 Dec 22
Vigil Neuroscience Announces First Patient Dosed in the IGNITE Phase 2 Clinical Trial to Evaluate VGL101 in Patients with ALSP
4:39pm
8-K
1n1gya3ky3 58
6 Dec 22
Regulation FD Disclosure
4:06pm
8-K
m3c r95szd09oeuq0gc
10 Nov 22
Vigil Neuroscience Reports Third Quarter 2022 Financial Results and Provides Business Update
7:05am
8-K
7i77ivnbh
2 Nov 22
Regulation FD Disclosure
12:00am
EFFECT
yj6ulggx0i543
17 Oct 22
Notice of effectiveness
12:15am
CORRESP
yucou47
12 Oct 22
Correspondence with SEC
12:00am
UPLOAD
0buhzp
11 Oct 22
Letter from SEC
12:00am
D
dwr2j8l
29 Aug 22
$75M in equity / options / securities to be acquired, sold $75M, 9 investors
4:23pm
8-K
cbk1iti6b0di
12 Aug 22
Vigil Neuroscience Announces $75 Million Private Placement Financing
4:06pm
8-K
4668deypbvrhk 1gcti
8 Aug 22
Vigil Neuroscience Reports Second Quarter 2022 Financial Results and Provides Business Update
7:12am
8-K
bkeigu b7tf2
28 Jul 22
Departure of Directors or Certain Officers
8:30am
8-K
hc9uc5ao7ztljvv0jr0t
10 Jun 22
Submission of Matters to a Vote of Security Holders
7:00am
8-K
3epe c2e2se4t8l4o7qq
7 Jun 22
Regulation FD Disclosure
7:11am
10-Q
6aiiklvcqbkrdp u5s41
12 May 22
Quarterly report
7:28am